Hotchkis & Wiley Capital Management
PETS icon

Hotchkis & Wiley Capital Management’s PetMed Express PETS Stock Holding History

Hotchkis & Wiley Capital Management’s Portfolio PETS Stock Details PETS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-514,543
Closed -$1.17M – 471
2026
Q1 		$1.17M Sell
514,543
-273,560
-35% -$794K ﹤0.01% 457
2025
Q4 		$2.52M Hold
788,103
– – 0.01% 452
2025
Q3 		$1.98M Sell
788,103
-38,800
-5% -$120K 0.01% 463
2025
Q2 		$2.75M Sell
826,903
-103,600
-11% -$369K 0.01% 456
2025
Q1 		$3.9M Sell
930,503
-43,600
-4% -$198K 0.01% 399
2024
Q4 		$4.7M Sell
974,103
-116,600
-11% -$546K 0.02% 395
2024
Q3 		$4.01M Sell
1,090,703
-204,590
-16% -$724K 0.01% 409
2024
Q2 		$5.25M Buy
1,295,293
+238,543
+23% +$1.02M 0.02% 389
2024
Q1 		$5.06M Buy
1,056,750
+317,600
+43% +$1.85M 0.02% 395
2023
Q4 		$5.59M Buy
739,150
+258,260
+54% +$2.12M 0.02% 391
2023
Q3 		$4.93M Buy
+480,890
New +$5.93M 0.02% 392
2022
Q3 		– Sell
-214,240
Closed -$4.26M – 546
2022
Q2 		$4.26M Buy
214,240
+19,280
+10% +$431K 0.02% 369
2022
Q1 		$5.03M Buy
194,960
+30,490
+19% +$791K 0.02% 357
2021
Q4 		$4.16M Buy
164,470
+11,800
+8% +$327K 0.01% 383
2021
Q3 		$4.1M Buy
152,670
+82,710
+118% +$2.38M 0.01% 386
2021
Q2 		$2.23M Buy
69,960
+8,600
+14% +$273K 0.01% 448
2021
Q1 		$2.16M Buy
61,360
+5,870
+11% +$204K 0.01% 429
2020
Q4 		$1.78M Buy
+55,490
New +$1.71M 0.01% 425
2020
Q3 		– Sell
-133,020
Closed -$4.74M – 473
2020
Q2 		$4.74M Sell
133,020
-9,690
-7% -$336K 0.02% 181
2020
Q1 		$4.11M Sell
142,710
-87,970
-38% -$2.31M 0.02% 194
2019
Q4 		$5.43M Buy
230,680
+56,540
+32% +$1.27M 0.02% 259
2019
Q3 		$3.14M Buy
174,140
+1,050
+0.6% +$17.3K 0.01% 311
2019
Q2 		$2.71M Buy
173,090
+114,380
+195% +$2.25M 0.01% 372
2019
Q1 		$1.34M Buy
+58,710
New +$1.32M 0.01% 438

Other funds holding PETS

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SPH
Steel Partners Holdings New York $78M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return

Hotchkis & Wiley Capital Management's PETS Position: Q2 2026 in Review

Hotchkis & Wiley Capital Management sold out of PetMed Express (PETS) in Q2 2026, closing a stake of 514,543 shares — an estimated $1.17M sold.

Hotchkis & Wiley Capital Management first reported a position in PETS in Q1 2019 and held it in 24 quarters. The position peaked at $5.59M in Q4 2023. 50 funds tracked by Wall St. Rank hold PETS as of Q2 2026.

  • Hotchkis & Wiley Capital Management reported no remaining PetMed Express position as of Q2 2026 after selling out during the quarter.
  • Hotchkis & Wiley Capital Management sold 514,543 PetMed Express shares in Q2 2026, an estimated $1.17M.
  • Hotchkis & Wiley Capital Management first reported a position in PetMed Express in Q1 2019 and held it in 24 quarters.
  • Hotchkis & Wiley Capital Management's PetMed Express position peaked at $5.59M in Q4 2023.
  • 50 funds tracked by Wall St. Rank held PetMed Express as of Q2 2026.

Based on Hotchkis & Wiley Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.